<DOC>
	<DOCNO>NCT00867009</DOCNO>
	<brief_summary>This study estimate response rate patient advance metastatic non-squamous Non-Small Cell Lung Cancer . Patients n't progress 4 6 cycle induction treatment pemetrexed , cisplatin cetuximab receive maintenance treatment pemetrexed cetuximab .</brief_summary>
	<brief_title>A Study Induction Maintenance Treatment Advanced Metastatic Non Squamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Patient must sign informed consent document clinical translational research . Patient must locally advance metastatic nonsquamous NonSmall Cell Lung Cancer . Patient must biological tissue available diagnosis tumor detection biomarkers ( translational research ) . Patient receive receive prior systemic anticancer therapy , immunotherapy , target therapy , biological therapy lung cancer ( except chemotherapy give surgery complete one year study entry ) . Patient allow prior radiation therapy long 25 % bone marrow include whole pelvis . Prior radiation therapy complete least 2 week prior first study drug . Thoracic radiation must complete 12 week study entry . You must recover toxic effect . Patient must least 1 measurable tumor lesion accord Response Evaluation Criteria Solid Tumors ( RECIST ) guideline . Patient must least able physically mobile , take care , must able perform light activity light housework office work . Test result assess function blood form tissue , kidney , liver must satisfactory . Females must sterile , postmenopausal contraception . Males must contraception sterile ( example postvasectomy ) . Patient symptomatic central nervous system metastasis . Patient active infection serious condition doctor think would make unable participate . Patient serious cardiac condition , heart attack , angina , heart disease within 6 month enter trial . Patient another form cancer superficial basal cell superficial squamous ( skin ) cell cancer , carcinoma situ cervix within last 5 year . Patient significant neurologic psychiatric disorder include dementia , seizures bipolar disorder . Patient moderate severe peripheral neuropathy Patient receive treatment within 30 day experimental drug . Patient major surgery within last 4 week . Patient previously receive treatment transduction inhibitor Epidermal Growth Factor Receptor ( EGFR ) target therapy . Patient prior know allergic/hypersensitivity reaction component study treatment . Females pregnant breastfeeding . Patient unable stop take 1.3 gram aspirin daily basis aspirin like medication ( nonsteroidal antiinflammatory drug : NSAIDs ) day cycle therapy . Patient unable unwilling take folic acid , injection vitamin B12 , corticosteroid . Patient fluid around lung abdomen ( pleural effusion ascites ) control drainage procedure . Patient receive yellow fever vaccination within previous 30 day plan . Patient know drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>